SHIKOKU KASEI HOLDINGS CORPORATION FY2026 Q2 Earnings Report

Quick View

Executive Summary

The establishment of price revisions and an improved mix of high-value-added products, combined with the contribution from M&A in the Chemicals Business, resulted in higher revenue and earnings, with earnings growth substantially outpacing revenue growth and reflecting qualitative improvement. Revenue was ¥45.84B (+34.1% year on year), Operating Income was ¥9.44B (+79.7%), Ordinary Income was ¥9.69B (+86.2%), and Net Income attributable to owners of the parent was ¥6.66B (+78.7%). The Operating Income margin improved significantly to 20.6% from 15.4% in the previous year, with operating leverage, in addition to the revenue growth effect, supporting earnings growth.

Factors Affecting Business Performance

【Revenue】Revenue was ¥45.84B (+34.1% year on year), with the Chemicals Business driving growth at ¥35.79B (+46.4%), accounting for 78.1% of total company revenue. The Building Materials Business posted ¥9.53B (+4.0%), representing only modest revenue growth. In Chemicals, Inorganic Chemicals, Organic Chemicals, and Fine Chemicals all recorded double-digit growth, supported by the establishment of price revisions and a shift in demand toward high-value-added products. The consolidation of Indonesia-based PT Timuraya Tunggal also contributed to revenue growth.

【Profit and Loss】Operating Income was ¥9.44B (+79.7%), while the gross margin improved from the previous year to 43.9% and the SG&A expense ratio declined to 23.3%, expanding the Operating Income margin to 20.6% from 15.4% in the previous year. The Chemicals Business recorded a high segment profit margin of 25.1% and generated nearly all of the Company’s total profit. The Building Materials Business expanded its profit from a loss, recording Operating Income of ¥0.31B (+374.2%), although its profit margin remained low at 3.3%. Ordinary Income was ¥9.69B (+86.2%), supported by a foreign exchange gain of ¥0.18B. An impairment loss of ¥0.23B related to the organizational restructuring of the Building Materials Business was recorded as an extraordinary loss, but this was almost offset by extraordinary income of ¥0.50B, including a gain on the sale of investment securities of ¥0.29B, resulting in a limited impact on Net Income. This was a notable earnings report characterized by higher revenue and earnings, with the earnings growth rate exceeding the revenue growth rate and indicating structural improvement in profitability.

Segment Analysis

The Chemicals Business is the Company’s earnings base, with revenue of ¥35.79B (+46.4%), Operating Income of ¥8.98B (+76.7%), and a profit margin of 25.1%. The Building Materials Business posted revenue of ¥9.53B (+4.0%) and Operating Income of ¥0.31B (+374.2%), progressing toward a return to profitability; however, its profit margin of 3.3% remained low compared with the Chemicals Business, and it recorded an impairment loss of ¥0.23B related to organizational restructuring. Other Businesses reported revenue of ¥0.68B (-3.7%) and Operating Income of ¥0.01B (-72.5%), recording lower earnings despite their small scale. The substantial difference in profitability among segments indicates that the Company’s high dependence on Chemicals determines its overall profit margin.

Key Financial Indicators

【Profitability】The Operating Income margin of 20.6% (15.4% in the previous year) and Net Income margin of 14.5% (11.0% in the previous year) both improved significantly from the previous year, reflecting simultaneous improvement in the gross margin to 43.9% (42.5% in the previous year) and a decline in the SG&A expense ratio to 23.3% (27.1% in the previous year). 【Cash Flow Quality】Operating Cash Flow (OCF) was ¥5.99B, only 0.90 times Net Income of ¥6.66B, with a ¥2.70B increase in accounts receivable being the primary source of pressure. 【Investment Efficiency】ROE was 6.4%; considered together with total asset turnover of 0.29 times and financial leverage of 1.55 times, the improvement in ROE for the period depended primarily on higher profit margins. 【Financial Soundness】The Equity Ratio remained high at 64.6% (65.0% in the previous year). Against cash and deposits of ¥36.76B, interest-bearing debt was in the ¥20B range in total, indicating that financial conservatism has not been compromised.

Cash Flow Analysis

Operating Cash Flow was ¥5.99B, increasing by +40.9% from ¥4.25B in the previous year; however, compared with Net Income of ¥6.66B, it remained at 0.90 times Net Income. The ¥2.70B increase in accounts receivable accompanying revenue growth, a ¥0.22B increase in inventories, and a ¥0.78B decrease in accounts payable put pressure on cash generation. Investing Cash Flow was -¥1.62B, reflecting investment activities centered on capital expenditures of ¥2.70B. As a result, free cash flow was positive at ¥4.37B, securing a level that could be covered with internal funds while continuing growth investments. Financing Cash Flow was -¥3.23B; although long-term borrowings increased by ¥0.47B, repayments of existing borrowings of ¥6.52B and dividend payments of ¥1.30B reduced funds. The fact that the increase in working capital accompanying revenue expansion is slowing the growth of cash generation is an important point to monitor from the perspective of future cash conversion efficiency.

Quality of Earnings

Current-period earnings were primarily derived from operating activities, and the impact of nonrecurring items was limited. Non-operating income of ¥0.58B (1.3% of revenue) was mainly attributable to dividend income of ¥0.14B and foreign exchange gains of ¥0.18B, and was strongly recurring in nature. Extraordinary income of ¥0.50B (including a gain on the sale of investment securities of ¥0.29B) and extraordinary losses of ¥0.49B (including an impairment loss of ¥0.23B in the Building Materials Business and a loss on disposal of fixed assets of ¥0.06B) almost offset each other, resulting in a limited net impact of approximately +¥0.01B on Net Income. The gap between Ordinary Income of ¥9.69B and Net Income of ¥6.66B was primarily attributable to income taxes of ¥3.15B (effective tax rate of 32.5%), with no structural distortion observed. Meanwhile, the fact that OCF was below Net Income reflects the accounting accrual arising from the increase in accounts receivable accompanying revenue growth. Although earnings quality was good, the time lag in cash conversion should be noted.

Earnings Forecast and Guidance

The full-year forecast calls for Revenue of ¥94.00B (+32.9% year on year), Operating Income of ¥18.00B (+65.6%), and Ordinary Income of ¥18.40B (+54.3%). First-half progress rates were 48.8% for Revenue, 52.4% for Operating Income, and 52.7% for Ordinary Income, with all three progressing at a pace slightly above the 50% quarterly benchmark. If the price revision effects and improved high-value-added product mix observed in the first half continue into the second half, results may be in line with or exceed the plan. Conversely, a reversal in raw material and foreign exchange conditions could create headwinds for margins.

Shareholder Returns

The interim dividend was ¥30 per share (¥25 in the same period of the previous year), representing an increase from the previous year. The payout ratio based on Net Income was approximately 40% based on the interim dividend, and sufficient capacity to pay dividends has been secured based on the levels of OCF and free cash flow (¥4.37B). In addition, the Company conducted a 2-for-1 stock split effective July 1, 2026; excluding the stock split, the full-year dividend forecast is ¥50 for the year-end dividend and ¥80 in total for the full year. No share repurchases were conducted during the first half, and dividends remain the primary form of shareholder returns.

Risk Factors

1. Segment concentration risk: The Chemicals Business accounts for 78.1% of revenue and the majority of Operating Income, resulting in high sensitivity to supply-demand and pricing trends in that business. The Building Materials Business has a low profit margin of 3.3%, and diversification of the earnings base remains limited.

2. Working capital and cash conversion risk: Accounts receivable increased by +32.0% from the previous year, while OCF remained at 0.90 times Net Income. A lengthening collection cycle during a period of revenue growth could affect future cash-generating capacity.

3. M&A integration and goodwill risk: The consolidation of PT Timuraya Tunggal resulted in goodwill of ¥1.99B and a significant increase in intangible assets. The purchase price allocation remains provisional, and amortization expenses or asset allocation could change upon finalization.

Industry Benchmark (Reference; Compiled by the Company)

Industry Benchmark (manufacturing)

Profitability and Returns

The Company’s Operating Income margin and Net Income margin both substantially exceed the industry median and are at high levels within the industry.

Growth and Capital Efficiency

The Revenue growth rate also substantially exceeds the industry median, placing the Company among the high-growth group within the industry.

※Source: Compiled by the Company

Key Points from the Earnings Report

1. The Operating Income margin expanded to 20.6% from 15.4% in the previous year. The simultaneous improvement in the gross margin and decline in the SG&A expense ratio is noteworthy as a structural change indicating the establishment of price revision effects and the high-value-added product mix.

2. Full-year progress rates of 48.8% for Revenue and 52.4% for Operating Income exceed standard progress levels. Assuming a neutral environment in the second half, results are expected to finish in line with the plan.

3. The +32.0% increase in accounts receivable and the OCF/Net Income ratio of 0.90 times indicate that the expansion of working capital accompanying revenue growth is creating a time lag in cash generation. Trends in future collection management will be a factor influencing cash flow quality.

Theoretical Share Price (Reference Value)

Sensitivity: ¥1,271–¥1,346 at ±1% for the cost of equity, and ¥1,305–¥1,312 at ±0.1 for ω.

Notes:

• Net assets as of the quarter-end are used (there is a timing difference from the full-year forecast).
• As net assets include non-controlling interests, the theoretical value may be calculated somewhat higher.

(Calculation model: Residual Income Model (Ohlson-type, explicit 5-year fade) / Interest rate reference month: 2026-07 / Mechanically calculated value based solely on publicly disclosed data; this is not a forecast of the market share price or a recommendation of any specific investment action, and does not predict or guarantee the future share price.)

---

This report is an earnings analysis document automatically generated by AI based on XBRL earnings summary data. It does not recommend investment in any specific security. The industry benchmarks are reference information compiled by the Company based on publicly disclosed earnings data. Investment decisions should be made at your own discretion and responsibility, after consulting with a professional as necessary.

---End of Report---

---

AI Financial Analysis

Executive Summary

FY2026 Q2 was a very strong earnings period for Shikoku Kasei Holdings, with revenue growth, margin expansion and profit growth materially outpacing sales. Revenue rose 34.1% year on year to ¥45.84bn. Operating income increased 79.7% to ¥9.44bn, lifting the operating margin to 20.6% from 15.4% in the prior-year period, an expansion of 520 basis points. Ordinary income grew 86.2% to ¥9.69bn, slightly exceeding operating income because non-operating income exceeded non-operating expenses. Profit attributable to owners of the parent rose 78.7% to ¥6.66bn. The net profit margin expanded to 14.5% from approximately 10.9%, an increase of roughly 360 basis points. Gross margin improved to 43.9% from 42.5%, while SG&A rose only 15.4%, substantially below revenue growth, demonstrating favorable operating leverage. The Chemicals business was the core earnings contributor, producing ¥8.98bn of segment profit, or nearly the entire consolidated segment-profit base. The acquisition of PT Timuraya Tunggal and its subsidiary added ¥8.16bn of assets to Chemicals and contributed to the substantial expansion in goodwill and intangible assets. Operating cash flow of ¥5.99bn was 0.90x net income, supporting earnings conversion but remaining below full cash coverage. Free cash flow was positive at ¥4.37bn after ¥2.70bn of capital expenditure, providing capacity for dividends and investment. Nevertheless, OCF-to-EBITDA cash conversion was weak at 0.52x, principally reflecting working-capital absorption including a ¥2.70bn increase in trade receivables and a ¥0.78bn decline in trade payables. Manufacturing working-capital indicators require attention: reported annualized DSO of 80 days, annualized DIO of 124 days, and a 125-day annualized cash conversion cycle are elevated. R&D expense increased to ¥1.17bn, but its 2.6% revenue intensity remains below the 3% monitoring threshold, even though it can be consistent with a mature chemical/materials portfolio. The ¥2.28bn impairment charge in Building Materials partly offset a ¥2.86bn gain on sales of investment securities, leaving the net extraordinary contribution to pre-tax profit modest. The revised full-year plan calls for revenue of ¥94.0bn, operating income of ¥18.0bn and parent profit of ¥12.6bn; Q2 progress is broadly in line with the revenue target but ahead of the standard halfway level for operating and net profit. The main forward issues are the sustainability of Chemicals’ elevated profitability, integration and purchase-price-allocation execution for the Indonesian acquisition, conversion of profits into cash, and normalization of working capital.

Profitability Analysis

Annualized DuPont ROE is 12.9%, comprising a 14.5% net profit margin, 0.575x asset turnover and 1.55x financial leverage. The primary driver of the strong return profile is margin, rather than leverage: net margin expanded by about 360bp year on year and operating margin by 520bp to 20.6%. Asset turnover is moderate for a manufacturer with meaningful PPE and investment-security holdings, while financial leverage is conservative and does not represent an aggressive source of ROE. Gross profit increased 38.6% to ¥20.13bn, faster than revenue, producing a 140bp gross-margin improvement. SG&A increased 15.4% to ¥10.69bn versus 34.1% revenue growth, so SG&A-to-sales fell to 23.3% from 27.1%; this was the principal operating-leverage mechanism behind operating-profit growth. EBITDA grew to ¥11.49bn and the EBITDA margin reached 25.1%, reinforcing that profit expansion was generated at the operating level. The Chemicals segment is the core business, with revenue of ¥357.87bn? No, ¥35.79bn and segment profit of ¥8.98bn, implying a 25.1% segment margin, compared with Building Materials revenue of ¥9.54bn and segment profit of ¥0.31bn, or a 3.3% margin. Chemicals revenue increased 46.5% year on year and segment profit rose 76.7%, supported by growth across inorganic chemicals (+45.7%), organic chemicals (+26.6%), and Fine Chemicals (+69.5%). Building Materials revenue rose 4.0%, but segment profit improved from ¥0.66bn to ¥0.31bn; despite the percentage increase, its absolute profitability remains structurally much lower than Chemicals. The tax burden was 0.687, equivalent to a 32.5% effective tax rate, modestly below the normal 0.70 benchmark but not a material constraint on returns. Interest burden was 1.028 because pre-tax income slightly exceeded EBIT, reflecting net non-operating income; interest expense is well contained. The 12.9% annualized ROE is good but remains below the 15% level generally associated with excellent returns; further improvement depends more on sustainable margins and working-capital efficiency than on balance-sheet leverage.

Growth Assessment

Top-line momentum was broad within Chemicals, where Fine Chemicals was the fastest-growing revenue category at 69.5% year on year to ¥13.67bn. Inorganic chemicals increased 45.7% to ¥10.62bn and organic chemicals rose 26.6% to ¥11.49bn. Building Materials was comparatively subdued: exterior revenue was broadly flat at ¥8.48bn, while wall-material revenue increased to ¥1.05bn from ¥0.64bn. The Q2 result suggests the group’s growth mix has shifted more decisively toward higher-margin Chemicals, which explains the significant consolidated margin uplift. The acquisition of PT Timuraya Tunggal and PT Pradipa Persada is an additional source of Chemicals growth, with ¥8.16bn of acquired segment assets recorded on a provisional purchase-price allocation. Full-year revenue guidance of ¥94.0bn implies 48.8% progress at Q2, close to the normal 50% seasonal benchmark. Operating-income progress is 52.4% and parent-profit progress is 52.9%, each approximately 2-3 percentage points above the normal halfway level; this supports the revised forecast but does not alone establish a material full-year beat. The full-year forecast embeds 32.9% sales growth and 65.6% operating-income growth, so the company must retain much of the first-half margin gain through the second half. Revenue growth has increased receivables by 32.0% to ¥19.99bn, while raw materials increased 59.1% to ¥7.39bn and construction in progress more than doubled to ¥6.68bn; these trends indicate active expansion but raise execution and cash-conversion requirements. CapEx was ¥2.70bn, 1.32x depreciation, indicating investment above replacement needs. R&D spending rose 17.1% to ¥1.17bn but lagged revenue growth, reducing intensity to 2.6%. For a mature chemicals and building-materials manufacturer this level is not necessarily inadequate, but sustained high-margin growth will require continued process, product and application-development investment.

Financial Health

Liquidity is exceptionally strong, with a 305.8% current ratio, a 273.0% quick ratio and ¥60.90bn of working capital. Cash and deposits of ¥36.76bn cover short-term loans of ¥5.47bn by 6.71x, substantially mitigating refinancing and near-term maturity-mismatch risk. Total interest-bearing debt was ¥22.96bn, consisting of ¥5.47bn of short-term loans and ¥17.48bn of long-term loans; only 23.8% of debt is short term. Debt-to-equity is a conservative 0.55x, debt-to-capital is 18.2%, and Debt/EBITDA is 2.00x, all consistent with a sound investment-grade-style balance-sheet profile. Interest coverage is robust at 32.44x on EBIT and 39.47x on EBITDA, leaving substantial capacity to service debt even if earnings normalize. Total equity rose ¥83.32bn year on year to ¥102.93bn, supported by retained earnings growth and ¥3.08bn of other comprehensive income, principally securities valuation gains. Investment securities remain substantial at ¥27.01bn, representing 17.0% of total assets; this provides balance-sheet value but introduces market-value volatility into comprehensive income and equity. Accounts receivable increased ¥4.85bn year on year to ¥19.99bn, broadly tracking high sales growth but requiring close collection discipline. Short-term loans increased ¥2.47bn, or 82.5%, and long-term loans increased ¥3.65bn, or 26.4%, consistent with funding needs associated with expansion and the acquisition. Goodwill rose from ¥0.66bn to ¥19.92bn and intangibles rose from ¥6.56bn to ¥25.54bn, both chiefly associated with the PT Timuraya Tunggal acquisition. These amounts remain limited relative to equity, at 1.9% for goodwill and 1.6% of assets for intangibles, so the group is not balance-sheet dependent on acquired intangible value. Asset-retirement obligations were ¥0.37bn, or approximately 0.7% of total liabilities, a manageable environmental-liability level for a chemical manufacturer.

Notable B/S Changes

Goodwill: +¥19.26bn (+2,918%) to ¥19.92bn - primarily reflects the PT Timuraya Tunggal acquisition; goodwill is still only 1.9% of equity, but final purchase-price allocation and impairment performance should be monitored. Intangible assets: +¥18.98bn (+289%) to ¥25.54bn - acquisition-related intangible recognition increases future amortization and valuation-monitoring requirements, though the balance remains only 1.6% of total assets. Short-term loans: +¥2.47bn (+82.5%) to ¥5.47bn - increased funding needs are evident, but cash covers short-term debt by 6.71x and there is no material maturity mismatch. Long-term loans: +¥3.65bn (+26.4%) to ¥17.48bn - debt increased alongside expansion and acquisition activity; Debt/EBITDA of 2.00x and interest coverage of 39.47x keep solvency risk contained. Accounts receivable: +¥4.85bn (+32.0%) to ¥19.99bn - broadly accompanies 34.1% revenue growth, but the 80-day annualized DSO makes collection and cash conversion a priority. Property, plant and equipment: +¥4.71bn (+15.5%) to ¥34.49bn, including construction in progress of ¥6.68bn versus ¥3.05bn - indicates an active investment pipeline; timely commissioning and return realization should be monitored. Raw materials: +¥2.75bn (+59.1%) to ¥7.39bn - inventory build exceeds sales growth and contributes to the elevated inventory-cycle risk, despite finished goods being broadly stable year on year. Investment securities: -¥0.45bn (-1.7%) to ¥27.01bn, while valuation gains lifted accumulated other comprehensive income - the portfolio remains a significant 17.0% of assets and introduces equity-market sensitivity.

Cash Flow Quality

Operating cash flow was ¥5.99bn, equivalent to 0.90x net income and therefore below full cash conversion but above the 0.8x level generally considered a material earnings-quality warning. The low cash-conversion alert is nevertheless valid: OCF/EBITDA was 0.52x, below the 0.7x threshold, indicating that a meaningful portion of operating earnings has not yet converted to cash during the first half. The principal operating-cash-flow pressure came from a ¥2.70bn increase in trade receivables and a ¥0.78bn decrease in trade payables. Inventory increased by ¥0.22bn in cash-flow terms, a comparatively smaller drag, but balance-sheet inventory composition and reported operating-cycle metrics still warrant caution. The annualized DSO alert of 80 days indicates collections materially slower than the manufacturing benchmark of less than 45 days and above the 60-day warning level. The annualized DIO alert of 124 days is also above the 90-day warning threshold; a separately reported 69-day inventory metric is likewise above the 60-day benchmark. The 125-day annualized cash conversion cycle exceeds the 120-day warning threshold, underscoring that working capital is the central cash-quality issue. Finished goods were ¥9.70bn, raw materials ¥7.39bn and work in process ¥0.32bn; the low work-in-process balance suggests the inventory burden is concentrated in inputs and completed products rather than a production bottleneck. Free cash flow was a positive ¥4.37bn after ¥2.70bn in capital expenditure, so the company generated internally funded cash after investment. CapEx was 1.32x depreciation, reflecting expansion or modernization rather than deferred maintenance. Investing cash flow was only negative ¥1.62bn despite a ¥4.44bn subsidiary acquisition because sales and redemptions of securities generated ¥5.83bn, which means recurring operating cash flow—not portfolio monetization—should remain the key source for future acquisition and capital-expenditure funding. The accruals ratio of 0.4% is low and favorable, suggesting no broad accrual-quality concern despite the short-term working-capital drag.

Dividend Sustainability

The Q2 dividend was ¥30.00 per share before the July 2026 two-for-one share split. The calculated dividend-only payout ratio is 40.4%, below the 60% sustainability benchmark and leaving a meaningful earnings retention buffer. Free cash flow covered the interim dividend by 1.62x, indicating that distributions are currently supported by post-capex cash generation. No share repurchases were reported in the current period, so the relevant capital-return measure is the dividend payout ratio rather than a total return ratio. Cash and deposits of ¥36.76bn, strong liquidity and modest leverage provide additional distribution capacity. However, the weaker 0.52x OCF/EBITDA conversion and extended cash conversion cycle mean that sustained dividend growth should be evaluated against cash realization, not accounting profit alone. The indicated pre-split full-year dividend assumption is ¥80.00 per share, comprising ¥30.00 interim and ¥50.00 year-end, although the company appropriately notes that the amounts cannot be mechanically added after the stock split. The revised dividend information and earnings forecast suggest management confidence in the improved earnings base. Dividend sustainability is therefore sound on current earnings, free-cash-flow and balance-sheet evidence, subject to maintaining working-capital discipline and avoiding a material deterioration in acquisition-related funding needs.

Risk Assessment

Business risks include Chemical-market cyclicality and raw-material, energy and foreign-exchange volatility could pressure the currently high 25.1% Chemicals segment margin. FX gains were ¥0.18bn in Q2, a modest 1.9% of operating income, but currency conditions can affect export competitiveness and imported-input costs., Building Materials generated only a 3.3% segment margin and recorded a ¥0.23bn impairment related to an organizational restructuring. This indicates that the business requires successful execution of production strengthening and resource reallocation to improve returns., R&D intensity of 2.6% is below the 3% monitoring threshold. While not unusual for mature materials operations, insufficient technology investment could weaken differentiation and pricing power if Chemicals-market requirements evolve., High finished-goods and raw-material balances, together with elevated inventory-day indicators, create risks of demand mismatch, holding costs and inventory valuation pressure..

Financial risks include Cash conversion of 0.52x OCF/EBITDA is weak. The root cause is working-capital absorption, particularly receivables growth and lower trade payables; the impact is reduced immediately available cash relative to EBITDA despite strong reported profit., Annualized DSO of 80 days is above the 60-day warning level. This may reflect customer mix and rapid sales growth, but it heightens collection, counterparty and cash-flow timing risk., Annualized DIO of 124 days, alongside a separately reported 69-day inventory measure above its 60-day benchmark, signals a lengthy inventory cycle. The impact is greater capital tied up in stock and potential exposure if chemicals or building-material demand slows., The annualized 125-day cash conversion cycle exceeds the 120-day warning threshold. This combines slow collection and inventory intensity, and could constrain internally funded growth if it persists., Acquisition funding and consolidation increased short-term and long-term borrowings, while goodwill rose to ¥19.92bn. Leverage remains conservative, but integration performance must validate the acquired asset base..

Key concerns include PT Timuraya Tunggal purchase-price allocation remains provisional. The acquired ¥8.16bn of Chemicals assets and ¥19.31bn of new goodwill require monitoring for final valuation adjustments, integration outcomes and any future impairment., The acquisition was sizeable relative to current-period revenue at roughly 9.7% based on ¥4.44bn cash acquisition outflow, making integration execution relevant even though goodwill ratios remain very low., The current earnings step-up is heavily concentrated in Chemicals. The sustainability of the consolidated 20.6% operating margin depends on retaining Chemicals profitability while improving the lower-return Building Materials operation., Comprehensive income exceeded net income because of securities valuation gains. Investment securities of ¥27.01bn expose equity to financial-market volatility, although this does not impair operating liquidity..

Investment Implications

Key takeaways include Revenue increased 34.1%, operating income 79.7% and parent profit 78.7%, with operating margin expanding 520bp to 20.6%., Chemicals is the core earnings engine, generating ¥35.79bn of revenue and ¥8.98bn of segment profit, versus Building Materials’ ¥9.54bn revenue and ¥0.31bn profit., The balance sheet is strong: current ratio 305.8%, D/E 0.55x, Debt/EBITDA 2.00x and EBITDA interest coverage 39.47x., Positive ¥4.37bn free cash flow and a 40.4% dividend payout ratio support capital-return capacity., Working-capital efficiency is the major financial-monitoring issue, given 0.52x OCF/EBITDA conversion, 80 annualized DSO days, 124 annualized DIO days and a 125-day annualized cash conversion cycle..

Metrics to watch include Chemicals segment revenue growth and segment margin, particularly Fine Chemicals demand and pricing., Building Materials margin recovery and restructuring outcomes following the ¥0.23bn impairment., Trade receivables, annualized DSO and collection performance., Finished-goods and raw-material inventory levels, annualized DIO and cash conversion cycle., OCF/EBITDA conversion and free cash flow after capex., Final purchase-price allocation, post-acquisition earnings contribution and goodwill impairment indicators for PT Timuraya Tunggal., Full-year operating-income progress versus the ¥18.0bn forecast and the persistence of first-half margin gains., R&D intensity and capex deployment relative to Chemicals growth opportunities..

Regarding relative positioning, The company combines excellent operating and EBITDA margins, a good 12.9% annualized ROE, and unusually strong liquidity with conservative leverage. Relative to manufacturing benchmarks, its principal comparative weakness is operating-capital efficiency rather than solvency: receivable days, inventory days and the cash conversion cycle are elevated. The low goodwill-to-equity ratio distinguishes the acquisition profile from highly leveraged serial acquirers, but the provisional purchase accounting and concentrated Chemicals-led earnings expansion remain important execution variables.